Skip to content

Our owners received 1st place at the Forbes Growth Awards 

In 2022, Forbes Hungary compiled the list of the 100 highest value 100% Hungarian-owned enterprises for the sixth time. The list was published in print in the November issue. 

We are pleased to announce that compared to last year’s standing, BioTechUSA has advanced 5 places to assume the 14th place in the EBIDTA-based ranking. On the occasion of the newly compiled list, the editorial office of the magazine organized the Forbes Hungarian 100 Gala this year again. We are extremely proud that co-owners CEO Bálint Lévai and Sales Director Balázs Lévai were presented the 1st place at the Forbes Growth Awards on the gala, together with Founder and Director Ferenc Lévai. And the reason for this is that over the last year, the BioTechUSA group has produced the fastest growth rate among the 100 highest value Hungarian companies. In addition to our dynamically increasing revenues, the jury also lauded our high-quality management, continuous sustainability efforts and the fact that we are at the forefront of innovation within our industry. 

The recognition was awarded by a 5-member professional jury including representatives of Forbes and the sponsors of the respective award. The most important requirement for the evaluation was that both the staff headcount and the sales revenue had to be increased by at least 20% in total over the last 3 years under review. Apart from such hard criteria, the jury also took other factors into consideration – including corporate social responsibility, the strength of the employer brand etc. – all of which has led them to pick the BioTechUSA group. 

Members of the jury: Hajnalka Csorbai (Strategic Director, Opten), Borbála Czakó (consultant), Gábor Szendrői (Managing Partner, CMBP), Anna Bánáti (Assistant Managing Director, Forbes). The award was presented by Márton Galambos, Editor-in-Chief at Forbes.

It is a great pleasure for us that despite last year’s challenging domestic and international market situation, the BioTechUSA team handled the obstacles with flying colors, not only achieving its best results to date, but also launching a larger volume of investments than ever before. We are grateful to the professional jury and the editorial office of Forbes for the award, offer our congratulations to all our colleagues, and thank all our customers for their faith and trust!”

– said CEO Bálint Lévai upon receiving the 1st place at the Forbes Growth Awards.